Crystal Watson

Short- and longer-term health-care resource utilization and costs associated with acute ischemic stroke

Barbara H. Johnson, Machaon Bonafede, Crystal Watson · ClinicoEconomics and Outcomes Research · 2016 · 145 citations · Full text

Life Sciences, Insurance, Health Economics +16

Treatment Patterns in the First Year After Initiating Tumor Necrosis Factor Blockers in Real-World Settings

Machaon Bonafede, Kathleen M. Fox, Crystal Watson et al. · Advances in Therapy · 2012 · 91 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +17

Characteristics, burden of illness, and physical functioning of patients with relapsing-remitting and secondary progressive multiple sclerosis: a cross-sectional US survey

H.J. Gross, Crystal Watson · Neuropsychiatric Disease and Treatment · 2017 · 77 citations · Full text

Nursing, Neurology, Health Assessment +13

Costs of Tumor Necrosis Factor Blockers Per Treated Patient Using Real-World Drug Data in a Managed Care Population

Vernon F. Schabert, Crystal Watson, George J Joseph et al. · Journal of Managed Care Pharmacy · 2013 · 64 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacotherapy +16

Cost per Treated Patient for Etanercept, Adalimumab, and Infliximab Across Adult Indications: a Claims Analysis

Machaon Bonafede, Shravanthi R. Gandra, Crystal Watson et al. · Advances in Therapy · 2012 · 59 citations

Pharmacy, Pharmacoeconomics, Pharmacotherapy +16